Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Secnidazole for Recurrent Bacterial Vaginosis
NCT05033743Phase 3Completed
- Sponsor
- Indiana University
- Start
- Jul 2021
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of secnidazole in bacterial vaginosis (BV), sponsored by Indiana University. Started Jul 2021; status: completed.
02
Drugs
secnidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT05033743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05033743.